US 12,168,086 B2
Hemostatic devices and methods of use
Satish Pulapura, Bridgewater, NJ (US); Fatima Buevich, Highland Park, NJ (US); Jorie S. Soskin, Edina, MN (US); Franklin R. Mansfield, Jacksonville, FL (US); Kai R. Worrell, Hopkins, MN (US); Charlie Wood, Delano, MN (US); Jorge Alberto Trevino Blanco, Minneapolis, MN (US); and Narvel M. Brooks, III, Minneapolis, MN (US)
Assigned to Medtronic, Inc, Minneapolis, MN (US)
Filed by MEDTRONIC INC., Minneapolis, MN (US)
Filed on Feb. 11, 2021, as Appl. No. 17/173,389.
Application 17/173,389 is a division of application No. 15/583,086, filed on May 1, 2017, granted, now 10,980,922.
Claims priority of provisional application 62/331,209, filed on May 3, 2016.
Prior Publication US 2021/0252197 A1, Aug. 19, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61L 31/16 (2006.01); A61K 31/496 (2006.01); A61K 31/65 (2006.01); A61L 31/04 (2006.01); A61L 31/10 (2006.01); A61L 31/14 (2006.01); A61M 37/00 (2006.01)
CPC A61L 31/16 (2013.01) [A61K 31/496 (2013.01); A61K 31/65 (2013.01); A61L 31/04 (2013.01); A61L 31/042 (2013.01); A61L 31/044 (2013.01); A61L 31/10 (2013.01); A61L 31/146 (2013.01); A61L 31/148 (2013.01); A61M 37/00 (2013.01); A61L 2300/406 (2013.01); A61L 2300/418 (2013.01); A61M 2205/0238 (2013.01)] 11 Claims
OG exemplary drawing
 
1. An anchorage device configured to surround an implantable medical device, the anchorage device comprising:
a mesh substrate formed from fibers of a first material and from a second material, wherein the first material comprises tranexamic acid and the second material is free of any hemostatic agents, the second material comprising rifampin and minocycline,
wherein the fibers are first fibers,
wherein the substrate comprises the first fibers and second fibers, the second fibers being made from the second material, and
wherein the substrate is completely biodegradable.